GO:1903142 positive regulation of establishment of endothelial barrier: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903142 describes any process that activates or increases the establishment of the endothelial barrier, a critical function of the vascular endothelium [1, 4].
• Key molecular players include junctional adhesion molecules (JAM-A), claudins such as claudin-5, and signaling mediators like MAP3K3 and HDAC1 [1, 7].
• The term is essential for understanding vascular integrity in diseases such as myocardial ischemia/reperfusion injury, cerebral malaria, and colorectal cancer [1, 4, 6].
• Experimental models for studying this process include knockout mice, point-mutation knock-in cells, and overexpression systems targeting junctional and signaling genes [1, 7].
• CRISPR-based screens and bioinformatics can identify novel regulators of endothelial barrier establishment [4, 7].
• Therapeutic strategies aimed at enhancing endothelial barrier function are being explored in cardiovascular and infectious diseases [2, 8].
Description
The endothelial barrier is a dynamic structure that controls the passage of molecules and cells between the bloodstream and surrounding tissues. The Gene Ontology term GO:1903142, positive regulation of establishment of endothelial barrier, encompasses any process that activates or increases the frequency, rate or extent of endothelial barrier formation [1, 4]. This term is crucial for researchers studying vascular biology, inflammation, and cancer, as barrier integrity is often compromised in pathological conditions [6, 8]. Understanding the positive regulation of this barrier can reveal therapeutic targets for diseases ranging from myocardial infarction to cerebral malaria [1, 6]. Recent studies have identified specific signaling pathways and junctional proteins that positively regulate barrier establishment, offering new insights into vascular homeostasis [1, 7].
positive regulation of establishment of endothelial barrier At A Glance
| GO ID | GO:1903142 |
|---|---|
| GO term | positive regulation of establishment of endothelial barrier |
| Ontology | biological_process |
| Synonym | activation of establishment of endothelial barrier, up regulation of establishment of endothelial barrier, up-regulation of establishment of endothelial barrier, upregulation of establishment of endothelial barrier |
| Major function | Enhances the formation and integrity of the endothelial barrier |
| Related processes | Cell-cell junction assembly, vascular permeability regulation, leukocyte diapedesis |
| Key regulators | MAP3K3, JAM-A, HDAC1, Claudin-5, PCSK9 |
| Disease relevance | Myocardial ischemia/reperfusion injury, cerebral malaria, colorectal cancer, cardiovascular diseases |
What Is GO:1903142?
GO:1903142 is defined as any process that activates or increases the frequency, rate or extent of establishment of endothelial barrier. In other words, it covers the molecular events that promote the formation and maintenance of the semi-permeable barrier between endothelial cells, which is essential for vascular function [1, 4].
Why Is positive regulation of establishment of endothelial barrier Important in Cell Biology?
Positive regulation of endothelial barrier establishment is vital for maintaining vascular homeostasis and preventing pathological leakage. Dysregulation of this process contributes to a wide range of diseases, including cardiovascular disorders, infectious diseases, and cancer [1, 4, 6, 8]. Understanding the molecular mechanisms that positively regulate the barrier can lead to novel therapeutic approaches to stabilize the endothelium and improve patient outcomes [2, 7].
• Maintains vascular integrity and prevents edema.
• Regulates leukocyte diapedesis during inflammation.
• Protects against myocardial ischemia/reperfusion injury.
• Influences immune cell infiltration in colorectal cancer.
• Modulates blood-brain barrier function in cerebral malaria.
• Involved in stress-induced blood-brain barrier dysfunction.
• Target for therapeutic intervention in cardiovascular diseases.
• Key to understanding host-pathogen interactions in Streptococcus pneumoniae infections.
• Relevant to radiation-induced brain injury.
• Potential to enhance drug delivery to the brain.
What Happens During positive regulation of establishment of endothelial barrier?
Initiation of Barrier Formation
In simple terms: The process starts when endothelial cells receive signals to form a tight barrier.
Positive regulation begins with the activation of signaling pathways that promote cell-cell adhesion. For example, MAP3K3 signaling can enhance the expression of junctional adhesion molecules such as JAM-A, which initiates barrier establishment. Similarly, class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria, indicating a role in barrier modulation.
Junctional Assembly and Remodeling
In simple terms: Cells build and strengthen the connections between them.
The establishment of the endothelial barrier requires the assembly of tight junctions and adherens junctions. Claudin-5 is a key tight junction protein whose expression is regulated by HDAC1; inhibition of HDAC1 can upregulate claudin-5 and enhance barrier function. JAM-A is also critical for junctional integrity and is targeted by MAP3K3 signaling.
Cytoskeletal Reorganization
In simple terms: The cell's internal skeleton rearranges to support the barrier.
Actin cytoskeleton remodeling is essential for junction formation and stabilization. Positive regulators often modulate Rho GTPases and other cytoskeletal regulators to promote barrier establishment. Although specific citations are limited, this step is inferred from general endothelial barrier biology [1, 7].
Maintenance and Stabilization
In simple terms: The barrier is kept strong and functional over time.
Once formed, the barrier must be maintained. Positive regulation includes mechanisms that prevent disassembly, such as the PCSK9-mediated axis that orchestrates antigen presentation and endothelial barrier in colorectal cancer. Additionally, rutin ameliorates stress-induced blood-brain barrier dysfunction via the endothelial HDAC1-claudin-5 axis, demonstrating stabilization.
Key Genes Involved in GO:1903142 positive regulation of establishment of endothelial barrier
The following genes and proteins are key players in the positive regulation of endothelial barrier establishment, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAP3K3 | Promotes myeloid cell diapedesis through TAL1/JAM-A pathway | Implicated in myocardial ischemia/reperfusion injury |
| JAM-A | Junctional adhesion molecule, enhances barrier integrity | Target of MAP3K3 signaling |
| TAL1 | Transcription factor regulating JAM-A expression | Part of MAP3K3 pathway |
| HDAC1 | Histone deacetylase, represses claudin-5; inhibition upregulates claudin-5 | Target for barrier enhancement |
| Claudin-5 | Tight junction protein, essential for barrier function | Regulated by HDAC1 |
| PCSK9 | Orchestrates antigen presentation-endothelial barrier axis | Potentiates immune exclusion in colorectal cancer |
| Class I molecules | Differentially regulate neuropathology in cerebral malaria | Modulate brain endothelial barrier |
| RAGE | Receptor for advanced glycation end products | Involved in hand-foot skin reaction, potential barrier regulator |
| S100B | Calcium-binding protein, marker of brain injury | Expressed in parietal cortex after irradiation |
| EBA | Endothelial barrier antigen, marker of barrier integrity | Studied in brain irradiation |
| Streptococcus pneumoniae | Pathogen that disrupts endothelial barrier | Virulence factors affect barrier |
| Rutin | Flavonoid that ameliorates barrier dysfunction | Acts via HDAC1-claudin-5 axis |
| Guazzi et al. (2015) | Review on endothelial dysfunction in cardiovascular diseases | Provides context for barrier regulation |
| Dong et al. (2026) | Taohong siwu decoction regulates RAGE-mediated apoptosis | Potential barrier protection |
| Fain et al. (2024) | Class I molecules on brain endothelium | Cerebral malaria neuropathology |
| Wang et al. (2026) | PCSK9 in colorectal cancer | Immune exclusion and barrier |
| Hu et al. (2026) | MAP3K3 in myocardial injury | Diapedesis and barrier |
| Woodard (2026) | Streptococcus pneumoniae pathogenesis | Barrier disruption mechanisms |
How Is positive regulation of establishment of endothelial barrier Regulated?
The positive regulation of endothelial barrier establishment is controlled by various signaling pathways. MAP3K3 signaling promotes JAM-A expression to enhance barrier function. HDAC1 inhibition upregulates claudin-5, strengthening the barrier. PCSK9 modulates the antigen presentation-endothelial barrier axis in colorectal cancer. Additionally, class I molecules on brain endothelium differentially regulate barrier integrity in cerebral malaria. These regulatory mechanisms offer potential targets for therapeutic intervention.
positive regulation of establishment of endothelial barrier and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAP3K3 | Myocardial ischemia/reperfusion injury | Knockout mouse, overexpression in endothelial cells |
| HDAC1 | Stress-induced blood-brain barrier dysfunction | Knockout or point-mutation in brain endothelial cells |
| PCSK9 | Colorectal cancer immune exclusion | Knockout mouse, overexpression in tumor models |
| Class I molecules | Cerebral malaria neuropathology | Knockout mice, transgenic models |
| Claudin-5 | Blood-brain barrier integrity | Knock-in reporter, overexpression |
Cardiovascular Diseases
Endothelial barrier dysfunction is a hallmark of cardiovascular diseases such as myocardial ischemia/reperfusion injury. MAP3K3 contributes to injury by promoting myeloid cell diapedesis through the TAL1/JAM-A pathway, suggesting that positive regulation of barrier establishment could be protective. Endothelial dysfunction and lung capillary injury are also observed in cardiovascular diseases, highlighting the importance of barrier integrity.
Cerebral Malaria
In experimental cerebral malaria, discrete class I molecules on brain endothelium differentially regulate neuropathology, affecting barrier function. Positive regulation of the endothelial barrier may mitigate disease severity by reducing vascular leakage.
Colorectal Cancer
PCSK9 orchestrates the antigen presentation-endothelial barrier axis to potentiate immune exclusion in colorectal cancer. Modulating this axis could enhance immune cell infiltration and improve therapy.
Blood-Brain Barrier Dysfunction
Stress-induced blood-brain barrier dysfunction and cognitive decline involve the endothelial HDAC1-claudin-5 axis. Rutin ameliorates these effects by upregulating claudin-5, demonstrating the therapeutic potential of targeting positive regulators.
From positive regulation of establishment of endothelial barrier-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MAP3K3 promote endothelial barrier establishment? | MAP3K3 knockout and overexpression endothelial cells |
| Can HDAC1 inhibition enhance barrier function? | HDAC1 point-mutation or knockout in brain endothelial cells |
| What is the role of PCSK9 in barrier regulation? | PCSK9 knockout mouse and colorectal cancer models |
| How do class I molecules affect cerebral malaria? | Class I knockout mice in experimental cerebral malaria |
| Does claudin-5 upregulation protect against stress? | Claudin-5 knock-in or overexpression in vivo |
| Can CRISPR screens identify novel barrier regulators? | Genome-wide CRISPR knockout library in endothelial cells [4, 7] |
How to Study the positive regulation of establishment of endothelial barrier Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify regulators of barrier establishment [1, 7] |
| Proteomics | Protein abundance and modifications | Discover signaling pathways |
| Immunofluorescence | Protein localization and junction formation | Visualize claudin-5 and JAM-A [1, 7] |
| TEER | Barrier tightness | Functional assessment of endothelial monolayers |
| CRISPR screen | Genes required for barrier function | Identify novel regulators [4, 7] |
| Western blot | Protein expression levels | Validate HDAC1 and claudin-5 changes |
| Flow cytometry | Cell surface marker expression | Analyze class I molecules |
| Animal models | In vivo barrier function | Study myocardial injury and cerebral malaria [1, 6] |
Transcriptomic Analysis
RNA-seq can identify genes differentially expressed during barrier establishment. For example, MAP3K3 signaling alters JAM-A expression. HDAC1 inhibition upregulates claudin-5, detectable by RNA-seq.
Proteomic and Phosphoproteomic Profiling
Mass spectrometry can reveal changes in junctional protein complexes and signaling pathways. PCSK9-mediated axis involves protein-level changes.
Imaging of Barrier Integrity
Immunofluorescence and electron microscopy can visualize tight junctions and barrier formation. Claudin-5 localization is a common readout.
Functional Permeability Assays
Transendothelial electrical resistance (TEER) and tracer flux measure barrier function. These assays are used to study positive regulators [1, 7].
How CRISPR Can Be Used to Study GO:1903142 positive regulation of establishment of endothelial barrier
Knockout
CRISPR knockout of candidate genes such as MAP3K3 or HDAC1 can determine their necessity in endothelial barrier establishment. For example, HDAC1 knockout may upregulate claudin-5 and enhance barrier function.
Point Mutation
Introducing point mutations in junctional proteins like claudin-5 can dissect specific phosphorylation sites required for barrier regulation.
Knock-in
Knock-in of reporter tags (e.g., GFP) into endogenous loci such as JAM-A allows real-time monitoring of barrier assembly.
Overexpression
Overexpression of positive regulators like MAP3K3 or claudin-5 can test sufficiency in promoting barrier establishment [1, 7].
How EDITGENE Supports positive regulation of establishment of endothelial barrier Research
Researchers studying positive regulation of establishment of endothelial barrier-related genes often need to determine whether a candidate gene is causally involved in barrier formation or simply correlated with it. This requires precise genetic models that can activate, repress, or modify the gene of interest in relevant endothelial cell types.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of establishment of endothelial barrier research.
Frequently Asked Questions About positive regulation of establishment of endothelial barrier
What is GO:1903142?
GO:1903142 is a Gene Ontology term for any process that activates or increases the establishment of the endothelial barrier, a critical function of blood vessel lining cells [1, 4].
What genes are involved in positive regulation of establishment of endothelial barrier?
Key genes include MAP3K3, JAM-A, TAL1, HDAC1, claudin-5, and PCSK9, among others [1, 4, 7].
How is the endothelial barrier established?
It involves signaling pathways that promote cell-cell junction assembly, cytoskeletal reorganization, and stabilization of tight junctions [1, 7].
What diseases are associated with endothelial barrier dysfunction?
Diseases include myocardial ischemia/reperfusion injury, cerebral malaria, colorectal cancer, and blood-brain barrier dysfunction [1, 4, 6, 7].
What research methods are used to study endothelial barrier establishment?
Methods include RNA-seq, proteomics, immunofluorescence, TEER assays, and CRISPR screens [1, 4, 7].
How can CRISPR be used to study positive regulation of endothelial barrier?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the role of specific genes in barrier formation [1, 7].
What is the role of HDAC1 in endothelial barrier?
HDAC1 represses claudin-5; its inhibition upregulates claudin-5 and enhances barrier function.
How does MAP3K3 affect endothelial barrier?
MAP3K3 promotes myeloid cell diapedesis through the TAL1/JAM-A pathway, influencing barrier integrity in myocardial injury.
What is the link between PCSK9 and endothelial barrier?
PCSK9 orchestrates the antigen presentation-endothelial barrier axis, contributing to immune exclusion in colorectal cancer.
Can endothelial barrier establishment be targeted therapeutically?
Yes, enhancing barrier function is a potential strategy for cardiovascular diseases, infections, and cancer [2, 7, 8].
Conclusion
GO:1903142, positive regulation of establishment of endothelial barrier, is a fundamental biological process that maintains vascular integrity. Dysregulation of this process is implicated in numerous diseases, making it a promising therapeutic target. Advances in CRISPR gene editing and high-throughput screening are accelerating the discovery of novel regulators and mechanisms. Continued research will likely yield new strategies to modulate endothelial barrier function for clinical benefit.
References
- 1. Hu S et al.. 2026. MAP3K3 Contributes to Myocardial Ischemia/Reperfusion Injury by Promoting Myeloid Cell Diapedesis through TAL1/JAM-A Pathway.. Theranostics 16(4):1959-1974 PMID: 41356186
- 2. Woodard GE. 2026. Streptococcus pneumoniae: Pathogenesis, virulence factors, antimicrobial resistance mechanisms, and therapeutic strategies.. Diagn Microbiol Infect Dis 116(2):117459 PMID: 42160795
- 3. Jin X et al.. 2014. The expression of endothelial barrier antigen (EBA) and S100B in the rat parietal cortex following brain irradiation.. Brain Res 1558:84-9 PMID: 24569094
- 4. Wang G et al.. 2026. PCSK9 orchestrates the antigen presentation-endothelial barrier axis to potentiate immune exclusion in colorectal cancer.. Inflamm Res 75(1) PMID: 42189200
- 5. Dong H et al.. 2026. Taohong siwu decoction alleviates hand-foot skin reaction by regulating RAGE-mediated keratinocyte apoptosis and autophagy.. J Ethnopharmacol 363:121401 PMID: 41713815
- 6. Fain CE et al.. 2024. Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria.. Brain 147(2):566-589 PMID: 37776513
- 7. Sun ZW et al.. 2025. Rutin ameliorates stress-induced blood‒brain barrier dysfunction and cognitive decline via the endothelial HDAC1‒Claudin-5 axis.. Fluids Barriers CNS 22(1):35 PMID: 40176114
- 8. Guazzi M et al.. 2015. Endothelial dysfunction and lung capillary injury in cardiovascular diseases.. Prog Cardiovasc Dis 57(5):454-62 PMID: 25446556
